Table 3.
Risk of albuminuria and left ventricular hypertrophy according to the control status of hypertension and diabetes mellitus
| Both hypertension and diabetes uncontrolled | Only diabetes controlled | Only hypertension controlled | Both hypertension and diabetes controlled | |
|---|---|---|---|---|
| Albuminuria | ||||
| Number of study subjects (n = 428) | 108 | 99 | 92 | 129 |
| Prevalence of albuminuria (%) | 41.7 | 21.2 | 18.5 | 14.0 |
| Odds ratio (95% confidence interval)* | ‐ | 0.40 (0.21‐0.76) | 0.31 (0.16‐0.61) | 0.22 (0.11‐0.43) |
| P value | ‐ | .005 | .001 | <.0001 |
| Left ventricular hypertrophy | ||||
| Number of study subjects (n = 766) | 205 | 173 | 171 | 217 |
| Prevalence of left ventricular hypertrophy (%) | 5.4 | 4.6 | 4.7 | 1.8 |
| Odds ratio (95% confidence interval)* | ‐ | 0.92 (0.35‐2.45) | 0.77 (0.29‐2.03) | 0.33 (0.10‐1.11) |
| P value | ‐ | .87 | .60 | .07 |
*
Adjusted for age, sex, body mass index, current smoking and alcohol intake, serum total cholesterol and triglycerides, and heart rate.